These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome. Costa AC; Grybko MJ Neurosci Lett; 2005 Jul; 382(3):317-22. PubMed ID: 15925111 [TBL] [Abstract][Full Text] [Related]
4. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo. Jing W; Guo F; Cheng L; Zhang JF; Qi JS Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation. Bisel BE; Henkins KM; Parfitt KD Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices. Zhang W; Miao J; Hao J; Li Z; Xu J; Liu R; Cao F; Wang R; Chen J; Li Z Peptides; 2009 Jun; 30(6):1197-202. PubMed ID: 19463756 [TBL] [Abstract][Full Text] [Related]
7. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors. Schotanus SM; Chergui K Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616 [TBL] [Abstract][Full Text] [Related]
8. Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo. Zhang JM; Wu MN; Qi JS; Qiao JT Synapse; 2006 Sep; 60(4):307-13. PubMed ID: 16786537 [TBL] [Abstract][Full Text] [Related]
9. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II. Watson JB; Khorasani H; Persson A; Huang KP; Huang FL; O'Dell TJ J Neurosci Res; 2002 Nov; 70(3):298-308. PubMed ID: 12391589 [TBL] [Abstract][Full Text] [Related]
11. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. Yamin G J Neurosci Res; 2009 Jun; 87(8):1729-36. PubMed ID: 19170166 [TBL] [Abstract][Full Text] [Related]
12. Recording long-term potentiation of synaptic transmission by three-dimensional multi-electrode arrays. Kopanitsa MV; Afinowi NO; Grant SG BMC Neurosci; 2006 Aug; 7():61. PubMed ID: 16942609 [TBL] [Abstract][Full Text] [Related]
13. Differences in the magnitude of long-term potentiation produced by theta burst and high frequency stimulation protocols matched in stimulus number. Hernandez RV; Navarro MM; Rodriguez WA; Martinez JL; LeBaron RG Brain Res Brain Res Protoc; 2005 May; 15(1):6-13. PubMed ID: 15878145 [TBL] [Abstract][Full Text] [Related]
14. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo. Zhang JF; Qi JS; Qiao JT Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963 [TBL] [Abstract][Full Text] [Related]
15. Antagonism of glutamate receptors in the CA1 to perirhinal cortex projection prevents long-term potentiation and attenuates levels of brain-derived neurotrophic factor. Kealy J; Commins S Brain Res; 2009 Apr; 1265():53-64. PubMed ID: 19232328 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices. Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164 [TBL] [Abstract][Full Text] [Related]
18. A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. Freir DB; Costello DA; Herron CE J Neurophysiol; 2003 Jun; 89(6):3061-9. PubMed ID: 12611943 [TBL] [Abstract][Full Text] [Related]
19. Chronic DHEAS administration facilitates hippocampal long-term potentiation via an amplification of Src-dependent NMDA receptor signaling. Chen L; Miyamoto Y; Furuya K; Dai XN; Mori N; Sokabe M Neuropharmacology; 2006 Sep; 51(3):659-70. PubMed ID: 16806295 [TBL] [Abstract][Full Text] [Related]
20. Synergistic requirements for the induction of dopaminergic D1/D5-receptor-mediated LTP in hippocampal slices of rat CA1 in vitro. Navakkode S; Sajikumar S; Frey JU Neuropharmacology; 2007 Jun; 52(7):1547-54. PubMed ID: 17433377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]